Laser manufacturer Lynton has partnered with Italian counterpart, DEKA to launch a new hair removal laser, the Motus AX.
The company claims the Alexandrite laser has been approved by the Food and Drug Administration (FDA) for use on all skin types. According to Lynton, the Alexandrite laser has traditionally only been safe to use on skin types I-III due to its melanin absorption capabilities, making it unsafe to use on any skin of colour.
However, the Motus AX aims to overcome these restrictions by combining DEKA's Moveo technology with the Alexandrite laser. Lynton claim that the Moveo technology stops the laser from losing energy by using light circular movements at a reduced power, avoiding wasted energy, making the process much less painful.
Lynton states that this feature offers aesthetic practitioners the advantages of ‘pain free’ laser hair removal on all skin types.
Dr Jonathon Exley, managing director at Lynton said, “At Lynton, we pride ourselves on not only being the UK’s largest laser and IPL manufacturer, but also on the quality of post-purchase support and technical service available to all our customers. I am delighted to announce this new partnership with DEKA lasers, as it opens the necessary channels for UK clinics to introduce revolutionary new technology like the Motus AX, but with the added support and reassurance of purchasing with Lynton.”
Paolo Salvadeo, general manager of the El:En group, who own DEKA, said, “I am delighted that Lynton have agreed to launch the DEKA brand in the UK. We have been seeking a suitable partner in the UK market and to have the opportunity to work with an award-winning company like Lynton is incredibly exciting. We look forward to great success!”